Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab

BACKGROUND: Investigating dynamic changes in blood-parameters and weight in patients with locally advanced non-small cell lung cancer (NSCLC) receiving durvalumab maintenance therapy after chemoradiotherapy (cCRT). Laboratory outcomes were determined based on the number of durvalumab administrations...

Descripción completa

Detalles Bibliográficos
Autores principales: Guggenberger, J., Kenndoff, S., Taugner, J., Käsmann, L., Flörsch, B., Belka, C., Eze, C., Manapov, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944024/
https://www.ncbi.nlm.nih.gov/pubmed/35331196
http://dx.doi.org/10.1186/s12885-022-09395-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944024/
https://www.ncbi.nlm.nih.gov/pubmed/35331196
http://dx.doi.org/10.1186/s12885-022-09395-6

Ejemplares similares